TY  - RPRT
TI  - Prospective, randomized, open-label, blinded-endpoint (PROBE) designed trials yield the same results as double-blind, placebo-controlled trials with respect to ABPM measurements.
AU  - David H Smith
AU  - Joel M Neutel
AU  - Yves Lacourcière
AU  - Joan Kempthorne-Rawson
PY  - 2003
DO  - 10.1097/00004872-200307000-00016
UR  - https://pubmed.ncbi.nlm.nih.gov/12817175/
ID  - 12817175
ER  -